201 related articles for article (PubMed ID: 32627074)
1. In vitro structure-activity relationship determination of 30 psychedelic new psychoactive substances by means of β-arrestin 2 recruitment to the serotonin 2A receptor.
Pottie E; Cannaert A; Stove CP
Arch Toxicol; 2020 Oct; 94(10):3449-3460. PubMed ID: 32627074
[TBL] [Abstract][Full Text] [Related]
2. Identification of psychedelic new psychoactive substances (NPS) showing biased agonism at the 5-HT
Pottie E; Dedecker P; Stove CP
Biochem Pharmacol; 2020 Dec; 182():114251. PubMed ID: 32998000
[TBL] [Abstract][Full Text] [Related]
3. Setup of a Serotonin 2A Receptor (5-HT2AR) Bioassay: Demonstration of Its Applicability To Functionally Characterize Hallucinogenic New Psychoactive Substances and an Explanation Why 5-HT2AR Bioassays Are Not Suited for Universal Activity-Based Screening of Biofluids for New Psychoactive Substances.
Pottie E; Cannaert A; Van Uytfanghe K; Stove CP
Anal Chem; 2019 Dec; 91(24):15444-15452. PubMed ID: 31725281
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and Functional Characterization of 2-(2,5-Dimethoxyphenyl)-
Pottie E; Kupriyanova OV; Shevyrin VA; Stove CP
ACS Chem Neurosci; 2021 May; 12(9):1667-1673. PubMed ID: 33906351
[TBL] [Abstract][Full Text] [Related]
5. In vitro assays for the functional characterization of (psychedelic) substances at the serotonin receptor 5-HT
Pottie E; Stove CP
J Neurochem; 2022 Jul; 162(1):39-59. PubMed ID: 34978711
[TBL] [Abstract][Full Text] [Related]
6. Structure-Activity Assessment and In-Depth Analysis of Biased Agonism in a Set of Phenylalkylamine 5-HT
Pottie E; Poulie CBM; Simon IA; Harpsøe K; D'Andrea L; Komarov IV; Gloriam DE; Jensen AA; Kristensen JL; Stove CP
ACS Chem Neurosci; 2023 Aug; 14(15):2727-2742. PubMed ID: 37474114
[TBL] [Abstract][Full Text] [Related]
7. Tolerance and Cross-Tolerance among Psychedelic and Nonpsychedelic 5-HT
de la Fuente Revenga M; Jaster AM; McGinn J; Silva G; Saha S; González-Maeso J
ACS Chem Neurosci; 2022 Aug; 13(16):2436-2448. PubMed ID: 35900876
[TBL] [Abstract][Full Text] [Related]
8. Structure-based discovery of nonhallucinogenic psychedelic analogs.
Cao D; Yu J; Wang H; Luo Z; Liu X; He L; Qi J; Fan L; Tang L; Chen Z; Li J; Cheng J; Wang S
Science; 2022 Jan; 375(6579):403-411. PubMed ID: 35084960
[TBL] [Abstract][Full Text] [Related]
9. 5-HT
Schmitz GP; Jain MK; Slocum ST; Roth BL
ACS Chem Neurosci; 2022 Aug; 13(16):2386-2398. PubMed ID: 35894503
[TBL] [Abstract][Full Text] [Related]
10. Discovery of β-Arrestin-Biased 25CN-NBOH-Derived 5-HT
Poulie CBM; Pottie E; Simon IA; Harpsøe K; D'Andrea L; Komarov IV; Gloriam DE; Jensen AA; Stove CP; Kristensen JL
J Med Chem; 2022 Sep; 65(18):12031-12043. PubMed ID: 36099411
[TBL] [Abstract][Full Text] [Related]
11. Molecular and clinical aspects of potential neurotoxicity induced by new psychoactive stimulants and psychedelics.
Rudin D; Liechti ME; Luethi D
Exp Neurol; 2021 Sep; 343():113778. PubMed ID: 34090893
[TBL] [Abstract][Full Text] [Related]
12. Chemistry and Structure-Activity Relationships of Psychedelics.
Nichols DE
Curr Top Behav Neurosci; 2018; 36():1-43. PubMed ID: 28401524
[TBL] [Abstract][Full Text] [Related]
13. Identification of 5-HT
Wallach J; Cao AB; Calkins MM; Heim AJ; Lanham JK; Bonniwell EM; Hennessey JJ; Bock HA; Anderson EI; Sherwood AM; Morris H; de Klein R; Klein AK; Cuccurazzu B; Gamrat J; Fannana T; Zauhar R; Halberstadt AL; McCorvy JD
Nat Commun; 2023 Dec; 14(1):8221. PubMed ID: 38102107
[TBL] [Abstract][Full Text] [Related]
14. Correction to: In vitro structure-activity relationship determination of 30 psychedelic new psychoactive substances by means of β-arrestin 2 recruitment to the serotonin 2A receptor.
Pottie E; Cannaert A; Stove CP
Arch Toxicol; 2020 Oct; 94(10):3461. PubMed ID: 32789674
[TBL] [Abstract][Full Text] [Related]
15. Structure of a Hallucinogen-Activated Gq-Coupled 5-HT
Kim K; Che T; Panova O; DiBerto JF; Lyu J; Krumm BE; Wacker D; Robertson MJ; Seven AB; Nichols DE; Shoichet BK; Skiniotis G; Roth BL
Cell; 2020 Sep; 182(6):1574-1588.e19. PubMed ID: 32946782
[TBL] [Abstract][Full Text] [Related]
16. Serotonin 2A Receptor (5-HT
Duan W; Cao D; Wang S; Cheng J
Chem Rev; 2024 Jan; 124(1):124-163. PubMed ID: 38033123
[TBL] [Abstract][Full Text] [Related]
17. The selective 5-HT
Jensen AA; Halberstadt AL; Märcher-Rørsted E; Odland AU; Chatha M; Speth N; Liebscher G; Hansen M; Bräuner-Osborne H; Palner M; Andreasen JT; Kristensen JL
Biochem Pharmacol; 2020 Jul; 177():113979. PubMed ID: 32298690
[TBL] [Abstract][Full Text] [Related]
18. Assessment of biased agonism at the A
Pottie E; Tosh DK; Gao ZG; Jacobson KA; Stove CP
Biochem Pharmacol; 2020 Jul; 177():113934. PubMed ID: 32224136
[TBL] [Abstract][Full Text] [Related]
19. Investigation of the 2,5-Dimethoxy Motif in Phenethylamine Serotonin 2A Receptor Agonists.
Marcher-Rørsted E; Halberstadt AL; Klein AK; Chatha M; Jademyr S; Jensen AA; Kristensen JL
ACS Chem Neurosci; 2020 May; 11(9):1238-1244. PubMed ID: 32212672
[TBL] [Abstract][Full Text] [Related]
20. Hallucinogens and Serotonin 5-HT
López-Giménez JF; González-Maeso J
Curr Top Behav Neurosci; 2018; 36():45-73. PubMed ID: 28677096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
